Pyxis Oncology, Inc. (PYXS)
1.73
+0.07
(+4.22%)
USD |
NASDAQ |
Jan 22, 14:34
Pyxis Oncology EPS Diluted (Quarterly): -0.3517 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| Spero Therapeutics, Inc. | -0.1312 |
| Processa Pharmaceuticals, Inc. | -1.808 |
| Alpha Teknova, Inc. | -0.0801 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.00M |
| Total Expenses (Quarterly) | 22.00M |
| Enterprise Value | 44.70M |
| Earnings Yield | -92.01% |
| Normalized Earnings Yield | -77.77 |